Meredith Selleck works in the field of Hematology. She researched medicine at New York Medical College. She has 1 awards "CMS Meaningful Use Stage 1 Certification". Meredith J. Selleck is also published. She has 1 publication published. The lastest publication: "Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.' Meredith Selleck accepts all Medicare patients.
NPI NUMBER | 1417908211 | |
NPPES Provider LastName | SELLECK | |
NPPES Provider FirstName | MEREDITH | |
NPPES Provider ZIPCode | 031062504 | |
NPPES Provider State | NH | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 369.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1417908211 |
Last Name Of The Provider | SELLECK |
First Name Of The Provider | MEREDITH |
View All |
![]() |
Dr. Peter H. Crow, MD
![]() |